Product NDC: | 0409-1638 |
Proprietary Name: | Precedex |
Non Proprietary Name: | DEXMEDETOMIDINE HYDROCHLORIDE |
Active Ingredient(s): | 100 ug/mL & nbsp; DEXMEDETOMIDINE HYDROCHLORIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-1638 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021038 |
Marketing Category: | NDA |
Start Marketing Date: | 19991217 |
Package NDC: | 0409-1638-02 |
Package Description: | 25 VIAL in 1 TRAY (0409-1638-02) > 2 mL in 1 VIAL |
NDC Code | 0409-1638-02 |
Proprietary Name | Precedex |
Package Description | 25 VIAL in 1 TRAY (0409-1638-02) > 2 mL in 1 VIAL |
Product NDC | 0409-1638 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DEXMEDETOMIDINE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 19991217 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | DEXMEDETOMIDINE HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC],General Anesthesia [PE] |